tDCS + Cognitive Training for Post-Stroke Cognitive Impairment
(TIPSCI Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a treatment combining mild brain stimulation and computer-based mental exercises can aid individuals with memory and thinking problems following a minor stroke. Participants will be divided into two groups: one will receive actual brain stimulation using Anodal transcranial Direct Current Stimulation (A-tDCS), while the other will receive a placebo version. Both groups will engage in the mental exercises. Researchers will assess brain activity and cognitive improvement before and after the treatment. Individuals who have experienced a minor stroke in the last month and have mild cognitive issues may be suitable candidates for this study. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could enhance cognitive recovery after a stroke.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this method is safe for post-stroke cognitive impairment?
Research has shown that anodal transcranial Direct Current Stimulation (A-tDCS) is safe and well-tolerated. Studies have found that tDCS is a safe, painless, and non-invasive method used to improve thinking skills in stroke patients. One study examined the safety of A-tDCS when applied to the brain area affected by a stroke and found no harm to the brain's structure or function. This suggests that A-tDCS can be safely used in stroke recovery without causing negative side effects.12345
Why are researchers excited about this trial?
Most treatments for post-stroke cognitive impairment focus on medication and physical rehabilitation. However, the treatment being studied, Anodal transcranial Direct Current Stimulation (A-tDCS), offers a unique approach. A-tDCS uses electrical currents to stimulate the brain's frontoparietal cortex, potentially enhancing the effects of cognitive therapy. Researchers are excited because this method could improve cognitive function by directly targeting brain regions involved in recovery, potentially offering faster and more effective results than traditional therapies.
What evidence suggests that this trial's treatments could be effective for post-stroke cognitive impairment?
Research has shown that anodal transcranial Direct Current Stimulation (A-tDCS), a treatment participants in this trial may receive, can improve thinking and memory in people with cognitive problems after a stroke. This treatment uses a gentle electrical current to stimulate the brain, strengthening brain connections. Studies have found that A-tDCS boosts brain activity and enhances thinking skills. It is considered a safe and practical option for recovery. Some research even suggests it can lead to long-term improvements by enhancing brain connectivity. Overall, A-tDCS offers hope for those facing cognitive challenges after a stroke.12367
Who Is on the Research Team?
Elisabeth B Marsh, MD
Principal Investigator
Johns Hopkins University
Are You a Good Fit for This Trial?
This trial is for adults over 18 who've had a minor stroke within the last week and show mild cognitive issues afterward. They must speak English, have manageable stroke symptoms (NIHSS <8), and be relatively independent (mRS 0-2). People with dementia, severe psychiatric illness, or those unable to attend sessions are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 15 sessions of anodal tDCS or sham intervention over 5 weeks, combined with computerized cognitive therapy (CCT)
Follow-up
Participants are monitored for safety and effectiveness after treatment, with MEG and cognitive assessments at 1, 3, and 6 months post-stroke
What Are the Treatments Tested in This Trial?
Interventions
- Anodal transcranial Direct Current Stimulation (A-tDCS)
- Sham Intervention
Anodal transcranial Direct Current Stimulation (A-tDCS) is already approved in United States, European Union, China for the following indications:
- Post-stroke cognitive impairment
- Post-stroke depression
- Aphasia
- Central post-stroke pain
- Post-stroke cognitive impairment
- Post-stroke depression
- Aphasia
- Central post-stroke pain
- Post-stroke cognitive impairment
- Post-stroke depression
- Aphasia
- Central post-stroke pain
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
National Institutes of Health (NIH)
Collaborator
University of Maryland, College Park
Collaborator